Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase

Oncogene

Volumn 25, Issue 44, 2006, Pages 5942-5952

  Zheng, R ^a   Iwase, A ^a   Shen, R ^a   Goodman Jr , O B ^a   Sugimoto, N ^b   Takuwa, Y ^b   Lerner, D J ^a   Nanus, D M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

G protein; Neuropetide; Neutral endopeptidase; Rho kinase; RhoGEF

Indexed keywords

BOMBESIN; BOMBESIN RECEPTOR; ENDOTHELIN 1; G PROTEIN COUPLED RECEPTOR; NEUROPEPTIDE; PROTEIN SUBUNIT; PROTEINASE; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL; CARCINOGENESIS; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME MECHANISM; HUMAN; HUMAN CELL; INHIBITION KINETICS; LEUKEMIA; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION;

BOMBESIN; CELL LINE, TUMOR; CELL MOVEMENT; CYTOSKELETON; ENDOTHELIN-1; ENZYME ACTIVATION; HUMANS; MALE; NEPRILYSIN; NEUROPEPTIDES; PROSTATIC NEOPLASMS; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION;

EID: 33749176646     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209586     Document Type: Article

References (76)

1. Aprikian AG, Tremblay L, Han K, Chevalier S. (1997). Int J Cancer 72: 498-504.
2. Arai K, Maruyama Y, Nishida M, Tanabe S, Takagahara S, Kozasa T et al. (2003). Mol Pharmacol 63: 478-488.
3. Bourne HR, Sanders DA, McCormick F. (1990). Nature 348: 125-132.
4. Braga V. (2000). Nat Cell Biol 2: E182-4.
5. Burridge K, Wennerberg K. (2004). Cell 116: 167-179.
6. Chikumi H, Fukuhara S, Gutkind JS. (2002). J Biol Chem 277: 12463-12473.
7. Dai J, Shen R, Sumitomo M, Goldberg JS, Geng Y, Navarro D et al. (2001). Clin Cancer Res 7: 1370-1377.
8. De Lombaert S, Erion MD, Tan J, Blanchard L, el-Chehabi L, Ghai RD et al. (1994). J Med Chem 37: 498-511.
9. Dhanasekaran N, Dermott JM. (1996). Cell Signal 8: 235-245.
10. Etienne-Manneville S, Hall A. (2002). Nature 420: 629-635.
11. Fukuhara S, Chikumi H, Gutkind JS. (2000). FEBS Lett 485: 183-188.
12. Fukuhara S, Chikumi H, Gutkind JS. (2001). Oncogene 20: 1661-1668.
13. Fukuhara S, Murga C, Zohar M, Igishi T, Gutkind JS. (1999). J Biol Chem 274: 5868-5879.
14. Glaven JA, Whitehead IP, Nomanbhoy T, Kay R, Cerione RA. (1996). J Biol Chem 271: 27374-27381.
15. Gohla A, Offermanns S, Wilkie TM, Schultz G. (1999). J Biol Chem 274: 17901-17907.
16. Grant K, Loizidou M, Taylor I. (2003). Br J Cancer 88: 163-166.
17. Hall A. (1998). Science 279: 509-514.
18. Hart MJ, Jiang X, Kozasa T, Roscoe W, Singer WD, Gilman AG et al. (1998). Science 280: 2112-2114.
19. Hart MJ, Sharma S, elMasry N, Qiu RG, McCabe P, Polakis P et al. (1996). J Biol Chem 271: 25452-25458.
20. Hersch E, Huang J, Grider JR, Murthy KS. (2004). Am J Physiol Cell Physiol 287: C1209-C1218.
21. Ishizaki T, Maekawa M, Fujisawa K, Okawa K, Iwamatsu A, Fujita A et al. (1996). EMBO J 15: 1885-1893.
22. Ishizaki T, Naito M, Fujisawa K, Maekawa M, Watanabe N, Saito Y et al. (1997). FEBS Lett 404: 118-124.
23. Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M et al. (2000). Mol Pharmacol 57: 976-983.
24. Iwase A, Shen R, Navarro D, Nanus DM. (2004). J Biol Chem 279: 11898-11905.
25. Jiang Y, Zhang W, Kondo K, Klco JM, StMartin TB, Dufault MR et al. (2003). Mol Cancer Res 1: 453-462.
26. Kajiyama H, Shibata K, Terauchi M, Morita T, Ino K, Mizutani S et al. (2005). Clin Cancer Res 11: 1798-1808.
27. Karnoub AE, Symons M, Campbell SL, Der CJ. (2004). Breast Cancer Res Treat 84: 61-71.
28. Kassis J, Lauffenburger DA, Turner T, Wells A. (2001). Semin Cancer Biol 11: 105-117.
29. Kitamura K, Shiraishi N, Singer WD, Handlogten ME, Tomita K, Miller RT. (1999). Am J Physiol Cell Physiol 276: C930-C937.
30. Kozasa T, Jiang X, Hart MJ, Sternweis PM, Singer WD, Gilman AG et al. (1998). Science 280: 2109-2111.
31. Kurose H. (2003). Life Sci 74: 155-161.
32. Leung T, Chen XQ, Manser E, Lim L. (1996). Mol Cell Biol 16: 5313-5327.
33. Li Z, Hannigan M, Mo Z, Liu B, Lu W, Wu Y et al. (2003). Cell 114: 215-227.
34. Liu B, Wu D. (2003). J Biol Chem 278: 2384-2387.
35. Lummen G, Virchow S, Rumenapp U, Schmidt M, Wieland T, Otto T et al. (1997). Naunyn Schmiedebergs Arch Pharmacol 356: 769-776.
36. Lyons LS, Burnstein KL. (2005). Mol Endocrinol. Epub ahead of print (29 December 2005).
37. Mackay DJG, Hall A. (1998). J Biol Chem 273: 20685-20688.
38. Mao J, Yuan H, Xie W, Wu D. (1998). Proc Natl Acad Sci USA 95: 12973-12976.
39. Matsui T, Amano M, Yamamoto T, Chihara K, Nakafuku M, Ito M et al. (1996). EMBO J 15: 2208-2216.
40. Nagakawa O, Ogasawara M, Fujii H, Murakami K, Murata J, Fuse H et al. (1998). Cancer Lett 133: 27-33.
41. Nagakawa O, Ogasawara M, Murata J, Fuse H, Saiki I. (2001). Int J Urol 8: 65-70.
42. Nakagawa T, Hocart SJ, Schumann M, Tapia JA, Mantey SA, Coy DH et al. (2005). Biochem Pharmacol 69: 579-593.
43. Offermanns S, Mancino V, Revel JP, Simon MI. (1997). Science 275: 533-536.
44. Papandreou CN, Usmani B, Geng Y, Bogenrieder T, Freeman R, Wilk S et al. (1998). Nat Med 4: 50-57.
45. Radhika V, Onesime D, Ha JH, Dhanasekaran N. (2004). J Biol Chem 279: 49406-49413.
46. Rankin S, Morii N, Narumiya S, Rozengurt E. (1994). FEBS Lett 354: 315-319.
47. Reuther GW, Lambert QT, Booden MA, Wennerberg K, Becknell B, Marcucci G et al. (2001). J Biol Chem 276: 27145-27151.
48. Richardson A, Parsons T. (1996). Nature 380: 538-540.
49. Ridley AJ, Hall A. (1992). Cell 70: 389-399.
50. Rosano L, Varmi M, Salani D, Di Castro V, Spinella F, Natali PG et al. (2001). Cancer Res 61: 8340-8346.
51. Rozengurt E. (2002). Trends Endocrinol Metab 13: 128-134.
52. Sander EE, ten Klooster JP, van Delft S, van der Kammen RA, Collard JG. (1999). J Cell Biol 147: 1009-1022.
53. Saurin JC, Fallavier M, Sordat B, Gevrey JC, Chayvialle JA, Abello J. (2002). Cancer Res 62: 4829-4835.
54. Schmidt A, Hall A. (2002). Genes Dev 16: 1587-1609.
55. Shen R, Sumitomo M, Dai J, Harris A, Kaminetzky D, Gao M et al. (2000). Endocrinology 141: 1699-1704.
56. Shipp M, Look A. (1993). Blood 82: 1052-1070.
57. Somlyo AV, Bradshaw D, Ramos S, Murphy C, Myers CE, Somlyo AP. (2000). Biochem Biophys Res Commun 269: 652-659.
58. Strathmann MP, Simon MI. (1991). Proc Natl Acad Sci USA 88: 5582-5586.
59. Sugden PH. (2003). J Mol Cell Cardiol 35: 871-886.
60. Sugimoto N, Takuwa N, Okamoto H, Sakurada S, Takuwa Y. (2003). Mol Cell Biol 23: 1534-1545.
61. Sumitomo M, Milowsky MI, Shen R, Navarro D, Dai J, Asano T et al. (2001). Cancer Res 61: 3294-3298.
62. Sumitomo M, Shen R, Nanus DM. (2005). Biochim Biophys Acta 1751: 52-59.
63. Sumitomo M, Shen R, Walburg M, Dai J, Geng Y, Navarro D et al. (2000). J Clin Invest 106: 1399-1407.
64. Suzuki N, Nakamura S, Mano H, Kozasa T. (2003). Proc Natl Acad Sci USA 100: 733-738.
65. Tangkijvanich P, Tam SP, Yee Jr HF. (2001). Hepatology 33: 74-80.
66. Turner M, Billadeau DD. (2002). Nat Rev Immunol 2: 476-486.
67. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T et al. (1997). Nature 389: 990-994.
68. Van Aelst L, D'Souza-Schorey C. (1997). Genes Dev 11: 2295-2322.
69. Wang Q, Liu M, Kozasa T, Rothestein JD, Sternweis PC, Neubig RR. (2004a). Methods Enzymol 389: 244-265.
70. Wang Q, Liu M, Kozasa T, Rothstein JD, Sternweis PC, Neubig RR. (2004b). J Biol Chem 279: 28831-28834.
71. Whitehead IP, Khosravi-Far R, Kirk H, Trigo-Gonzalez G, Der CJ, Kay R. (1996). J Biol Chem 271: 18643-18650.
72. Worthylake RA, Lemoine S, Watson JM, Burridge K. (2001). J Cell Biol 154: 147-160.
73. Xu J, Wang F, Van Keymeulen A, Herzmark P, Straight A, Kelly K et al. (2003). Cell 114: 201-214.
74. Yuan J, Slice LW, Rozengurt E. (2001). J Biol Chem 276: 38619-38627.
75. Zhao R, Seither R, Brigle KE, Sharina IG, Wang PJ, Goldman ID. (1997). J Biol Chem 272: 21207-21212.
76. Zhou K, Wang Y, Gorski JL, Nomura N, Collard J, Bokoch GM. (1998). J Biol Chem 273: 16782-16786.